CoChat

TGF-β and cancer

Open access
Reiss, Michael · 1999 · Microbes and Infection
Cited by 118

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The relationships between transforming growth factor-beta (TGF-beta) and cancer are varied and complex. The paradigm that is emerging from the experimental evidence accumulated over the past decade or so is that TGF-beta can play two different and opposite roles with respect to the process of malignant progression. During early stages of carcinogenesis, TGF-beta acts predominantly as a potent tumor suppressor and may mediate the actions of chemopreventive agents such as retinoids and nonsteroidal anti-estrogens. However, at some point during the development and progression of malignant neoplasms, bioactive TGF-betas make their appearance in the tumor microenvironment and the tumor cells escape from TGF-beta-dependent growth arrest. In many cases, this resistance to TGF-beta is the consequence of loss or mutational inactivation of the genes that encode signaling intermediates. These include the types I and II TGF-beta receptors, as well as receptor-associated and common-mediator Smads. The stage of tumor development or progression at which TGF-beta-resistant clones come to dominate the tumor cell population in different types of neoplasm remains to be defined. The phenotypic switch from TGF-beta-sensitivity to TGF-beta-resistance that occurs during carcinogenesis has several important implications for cancer prevention and treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1286-4579(99)00251-8

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 272

  1. Roberts, 1993, Physiological actions and clinical applications of transforming growth factor-beta (TGF--beta), Growth Factors, 8, 1, 10.3109/08977199309029129 · DOI · Paper page
  2. Weinberg, 1997, The cat and mouse games that genes viruses and cells play, Cell, 88, 573, 10.1016/S0092-8674(00)81897-8 · DOI
  3. Rozenblum, 1997, Tumor-suppressive pathways in pancreatic carcinoma, Cancer Res., 57, 1731
  4. Sporn, 1989, Transforming growth factor-beta and suppression of carcinogenesis, Princess Takamatsu Symp., 20, 259
  5. Markowitz, 1996, Tumor suppressor activity of the TGF--beta pathway in human cancers, Cytokine Growth Factor Rev., 7, 93, 10.1016/1359-6101(96)00001-9 · DOI · Paper page
  6. Pierce Jr, 1995, Mammary tumor suppression by transforming growth factor beta 1 transgene expression, Proc. Natl. Acad. Sci. USA, 92, 4254, 10.1073/pnas.92.10.4254 · DOI · Paper page
  7. Glick, 1994, Targeted deletion of the TGF--beta 1 gene causes rapid progression to squamous cell carcinoma, Genes Dev., 8, 2429, 10.1101/gad.8.20.2429 · DOI · Paper page
  8. Tang, 1998, Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency, Nature M, 4, 802, 10.1038/nm0798-802 · DOI · Paper page
  9. Shida, 1998, Estrogen-induced tumorigenesis in the pituitary gland of TGF--beta (+/-) knockout mice, Biochim. Biophys. Acta, 1407, 79, 10.1016/S0925-4439(98)00024-6 · DOI
  10. Thorup, 1997, Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats relationship to growth factor expression, Carcinogenesis, 18, 465, 10.1093/carcin/18.3.465 · DOI
  11. Wu, 1992, TGF--beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector, J. Cell Biol., 116, 187, 10.1083/jcb.116.1.187 · DOI · Paper page
  12. Wu, 1993, Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties, Cell Growth Differ., 4, 115
  13. Wang, 1997, Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition, Proc. Natl. Acad. Sci. USA, 94, 2386, 10.1073/pnas.94.6.2386 · DOI · Paper page
  14. Jakubczak, 1997, Enhanced mammary tumorigenesis in transgenic mice expressing a dominant negative type II TGF-β receptor under the control of the MMTV-LTR, Proc. Am. Assoc. Cancer Res., 38, 580
  15. Pasche, 1998, Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract, Cancer Res., 58, 2727
  16. Chen, 1999, Structural alterations of transforming growth factor-β receptor genes in cervical carcinoma, Int. J. Cancer, 82, 43, 10.1002/(SICI)1097-0215(19990702)82:1<43::AID-IJC9>3.0.CO;2-0 · doi:10.1002/(sici)1097-0215(19990702)82:1<43::aid-ijc9>3.0.co;2-0
  17. Zhu, 1998, Smad3 mutant mice develop metastatic colorectal cancer, Cell, 94, 703, 10.1016/S0092-8674(00)81730-4 · DOI · Paper page
  18. Takaku, 1998, Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes, Cell, 92, 645, 10.1016/S0092-8674(00)81132-0 · DOI · Paper page
  19. Sirard, 1998, The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo, Genes Dev., 12, 107, 10.1101/gad.12.1.107 · DOI · Paper page
  20. Reiss, 1997, Transfer of chromosome 18 into human head and neck squamous carcinoma cells Evidence for tumor suppression by Smad4/DPC4, Cell Growth Diff., 8, 407
  21. Grau, 1997, Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells, Cancer Res., 57, 3929
  22. Hunt, 1998, Overexpression of tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and agrowth inhibition in human carcinoma cells, Cancer Res., 58, 5656
  23. Zhou, 1998, Targeted deletion of smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells [In Process Citation], Proc. Natl. Acad. Sci. USA, 95, 2412, 10.1073/pnas.95.5.2412 · DOI · Paper page
  24. DeLarco, 1978, Growth factors from murine sarcoma virus-transformed cells, Proc. Natl. Acad. Sci. USA, 75, 4001, 10.1073/pnas.75.8.4001 · DOI · Paper page
  25. Corcione, 1993, Br. J. Haematol., 85, 684, 10.1111/j.1365-2141.1993.tb03209.x · doi:10.1111/j.1365-2141.1993.tb03209.x
  26. Cupp, 1993, Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS, Oncogene, 8, 2231
  27. Michelson, 1994, Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1, J. Virol., 68, 5730, 10.1128/jvi.68.9.5730-5737.1994 · DOI
  28. Cayrol, 1995, Identification of cellular target genes of the Epstein-Barr virus transactivator Zta activation of transforming growth factor beta igh3 (TGF--beta igh3) and TGF--beta 1, J. Virol., 69, 4206, 10.1128/jvi.69.7.4206-4212.1995 · DOI
  29. Schultz-Cherry, 1996, Influenza virus neuraminidase activates latent transforming growth factor beta, J. Virol., 70, 8624, 10.1128/jvi.70.12.8624-8629.1996 · DOI · Paper page
  30. Yoo, 1996, Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis, J. Clin. Invest., 97, 388, 10.1172/JCI118427 · DOI
  31. Dey, 1997, HPV 16 E6 oncoprotein stimulates the Transforming Growth Factor-beta-1 promoter In fibroblasts through a specific GC-rich sequence, Virology, 228, 190, 10.1006/viro.1996.8363 · DOI
  32. Creek, 1995, Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes, Adv. Exp. Med. Biol., 375, 117, 10.1007/978-1-4899-0949-7_11 · DOI
  33. Roberts, 1983, Transforming growth factors from neoplastic and nonneoplastic tissues, Fed. Proc., 42, 2621
  34. Nishimura, 1986, High level of beta-type transforming growth factor activity in human urine obtained from cancer patients Jpn J, Cancer Res., 77, 560
  35. Tsushima, 1996, High levels of transforming growth factor beta 1 in patients with colorectal cancer association with disease progression, Gastroenterology, 110, 375, 10.1053/gast.1996.v110.pm8566583 · DOI · Paper page
  36. Perry, 1997, Transforming growth factor beta as a clinical biomarker for prostate cancer, Urology 49, 151, 10.1016/S0090-4295(96)00426-8 · DOI
  37. Kong, 1995, Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor, Ann. Surg., 222, 155, 10.1097/00000658-199508000-00007 · DOI · Paper page
  38. Chopra, 1997, Serum levels of interleukins growth factors and angiogenin in patients with endometrial cancer, J. Cancer Res. Clin. Oncol., 123, 167
  39. Sminia, 1998, Plasma transforming growth factor beta levels in breast cancer patients, Oncol. Rep., 5, 485
  40. Maccallum, 1994, Expression of transforming growth factor beta mRNA isoforms in human breast cancer [see comments], Br. J. Cancer, 69, 1006, 10.1038/bjc.1994.197 · DOI
  41. Travers, 1988, Growth factor expression in normal benign and malignant breast tissue, Br. Med. J. (Clin. Res. Ed)., 296, 1621, 10.1136/bmj.296.6637.1621 · doi:10.1136/bmj.296.6637.1621
  42. Walker, 1992, Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast, Eur. J. Cancer, 28, 641, 10.1016/S0959-8049(05)80116-9 · DOI
  43. McCune, 1992, Localization of transforming growth factor-beta isotypes in lesions of the human breast [see comments], Hum. Pathol., 23, 13, 10.1016/0046-8177(92)90004-M · DOI
  44. Dalal, 1993, Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma, Am. J. Pathol., 143, 381
  45. Auvinen, 1995, Prognostic significance of TGF--beta 1 and TGF--beta 2 expressions in female breast cancer, Anticancer Res., 15, 2627
  46. De Jong, 1998, Expression of growth factors growth inhibiting factors and their receptors in invasive breast Cancer I An inventory in search of autocrine and paracrine loops, J. Pathol., 184, 44, 10.1002/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.0.CO;2-H · DOI · Paper page
  47. Gorsch, 1992, Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer, Cancer Res., 52, 6949
  48. Hirayama, 1992, Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer, Hum. Pathol., 23, 681, 10.1016/0046-8177(92)90325-W · doi:10.1016/0046-8177(92)90325-w
  49. Mizoi, 1993, Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas qualitative difference between cancer cells and stromal cells, Cancer Res., 53, 183
  50. Kai, 1996, Distribution of transforming growth factor-beta and its receptors in gastric carcinoma tissue, Jpn J. Cancer Res., 87, 296, 10.1111/j.1349-7006.1996.tb00220.x · doi:10.1111/j.1349-7006.1996.tb00220.x
  51. Morisaki, 1996, Immunosuppressive cytokines (IL-10 TGF--beta) genes expression in human gastric carcinoma tissues, J. Surg. Oncol., 63, 234, 10.1002/(SICI)1096-9098(199612)63:4<234::AID-JSO4>3.0.CO;2-D · doi:10.1002/(sici)1096-9098(199612)63:4<234::aid-jso4>3.0.co;2-d
  52. Naef, 1997, Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma, Int. J. Cancer, 71, 131, 10.1002/(SICI)1097-0215(19970410)71:2<131::AID-IJC1>3.0.CO;2-1 · doi:10.1002/(sici)1097-0215(19970410)71:2<131::aid-ijc1>3.0.co;2-1
  53. Mahara, 1994, Transforming growth factor beta 1 secreted from scirrhous gastric cancer cells is associated with excess collagen deposition in the tissue, Br. J. Cancer, 69, 777, 10.1038/bjc.1994.147 · DOI · Paper page
  54. Ura, 1991, Effects of transforming growth factor-beta released from gastric carcinoma cells on the contraction of collagen-matrix gels containing fibroblasts, Cancer Res., 51, 3550
  55. Yashiro, 1995, Establishment of two new scirrhous gastric cancer cell lines analysis of factors associated with disseminated metastasis, Br. J. Cancer, 72, 1200, 10.1038/bjc.1995.486 · doi:10.1038/bjc.1995.486
  56. Yashiro, 1996, Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts, Br. J. Cancer, 74, 1096, 10.1038/bjc.1996.496 · DOI
  57. Inoue, 1997, Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells, Jpn J. Cancer Res., 88, 152, 10.1111/j.1349-7006.1997.tb00360.x · DOI
  58. Cardillo, 1996, TGF--beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study, Arch. Anat. Cytol. Pathol., 44, 241
  59. Picon, 1998, A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1, Cancer Epidemiol. Biomarkers Prev., 7, 497
  60. Merz, 1994, Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate benign prostatic hyperplasia and prostatic cancer, World J. Urol., 12, 96, 10.1007/BF00184244 · DOI
  61. Truong, 1993, Association of transforming growth factor-beta 1 with prostate cancer an immunohistochemical study, Hum. Pathol., 24, 4, 10.1016/0046-8177(93)90055-L · DOI · Paper page
  62. Eastham, 1995, Transforming growth factor-beta 1 comparative immunohistochemical localization in human primary and metastatic prostate cancer, Lab. Invest., 73, 628
  63. Eklov, 1993, Lack of the latent transforming growth factor beta binding protein in malignant but not benign prostatic tissue, Cancer Res., 53, 3193
  64. Miyamoto, 1995, Expression of transforming growth factor-beta 1 in human bladder cancer, Cancer, 75, 2565, 10.1002/1097-0142(19950515)75:10<2565::AID-CNCR2820751025>3.0.CO;2-M · doi:10.1002/1097-0142(19950515)75:10<2565::aid-cncr2820751025>3.0.co;2-m
  65. Eder, 1997, Expression of transforming growth factors beta-1 beta 2 and beta 3 in human bladder carcinomas, Br. J. Cancer, 75, 1753, 10.1038/bjc.1997.299 · DOI
  66. Gold, 1994, Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium evidence for paracrine and autocrine action, Cancer Res., 54, 2347
  67. Comerci Jr, 1996, Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix, Cancer, 77, 1107, 10.1002/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.0.CO;2-5 · doi:10.1002/(sici)1097-0142(19960315)77:6<1107::aid-cncr16>3.0.co;2-5
  68. Kloen, 1997, Expression of transforming growth factor-beta (TGF--beta) isoforms in osteosarcomas TGF--beta3 is related to disease progression, Cancer, 80, 2230, 10.1002/(SICI)1097-0142(19971215)80:12<2230::AID-CNCR3>3.0.CO;2-Y · DOI · Paper page
  69. Bottinger, 1997, Expression of a dominant-negative mutant TGF--beta type II receptor in transgenic mice reveals essential roles for TGF--beta in regulation of growth and differentiation in the exocrine pancreas, Embo J., 16, 2621, 10.1093/emboj/16.10.2621 · DOI · Paper page
  70. Friedman, 1995, High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer, Cancer Epidemiol. Biomarkers Prev., 4, 549
  71. Doran, 1997, Oncogene and cytokine expression of human colorectal tumors responding to immunotherapy, J. Immunother., 20, 372, 10.1097/00002371-199709000-00006 · DOI
  72. Friess, 1993, Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival, Gastroenterology, 105, 1846, 10.1016/0016-5085(93)91084-U · DOI · Paper page
  73. Takanami, 1997, Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma results of an immunohistochemical study, J. Surg. Oncol., 64, 262, 10.1002/(SICI)1096-9098(199704)64:4<262::AID-JSO3>3.0.CO;2-7 · DOI
  74. Kim, 1998, Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients, Clin. Cancer Res., 4, 1625
  75. Murray, 1993, The prognostic significance of transforming growth factors in human breast cancer, Br. J. Cancer, 67, 1408, 10.1038/bjc.1993.261 · doi:10.1038/bjc.1993.261
  76. Welch, 1990, Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential, Proc. Natl. Acad. Sci. USA, 87, 7678, 10.1073/pnas.87.19.7678 · DOI · Paper page
  77. Arrick, 1992, Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1, J. Cell Biol., 118, 715, 10.1083/jcb.118.3.715 · DOI · Paper page
  78. Ueki, 1993, Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection, Jpn J. Cancer Res., 84, 589, 10.1111/j.1349-7006.1993.tb02017.x · DOI
  79. Oshima, 1996, TGF--beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis, Dev. Biol., 179, 297, 10.1006/dbio.1996.0259 · DOI · Paper page
  80. Mc Allister, 1994, Endoglin a TGF--beta binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1, Nat. Genet., 8, 345, 10.1038/ng1294-345 · DOI · Paper page
  81. McAllister, 1995, Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function, Hum. Mol. Genet., 4, 1983, 10.1093/hmg/4.10.1983 · DOI
  82. Johnson, 1996, Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2, Nat. Genet., 13, 189, 10.1038/ng0696-189 · DOI · Paper page
  83. Pepper, 1997, Transforming growth factor-beta vasculogenesis angiogenesis and vessel wall integrity, Cytokine Growth Factor Rev., 8, 21, 10.1016/S1359-6101(96)00048-2 · DOI · Paper page
  84. Ueki, 1992, Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis validity of neutralizing antibodies to block tumor growth, Biochim. Biophys. Acta, 1137, 189, 10.1016/0167-4889(92)90201-L · DOI
  85. De Jong, 1998, Expression of growth factors growth-inhibiting factors and their receptors in invasive breast Cancer II Correlations with proliferation and angiogenesis, J. Pathol., 184, 53, 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7 · DOI · Paper page
  86. Nakanishi, 1997, The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer, Int. J. Gynecol. Pathol., 16, 256, 10.1097/00004347-199707000-00011 · doi:10.1097/00004347-199707000-00011
  87. Choi, 1997, Relationship of transforming growth factor beta 1 to angiogenesis in gastric carcinoma, J. Korean Med. Sci., 12, 427, 10.3346/jkms.1997.12.5.427 · doi:10.3346/jkms.1997.12.5.427
  88. Merwin, 1990, Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis, J. Cell Physiol., 142, 117, 10.1002/jcp.1041420115 · DOI · Paper page
  89. Sankar, 1996, Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis, J. Clin. Invest., 97, 1436, 10.1172/JCI118565 · DOI · Paper page
  90. O'Mahony, 1998, Transforming growth factor-beta 1 inhibits generation of angiostatin by human pancreatic cancer cells, Surgery, 124, 388, 10.1016/S0039-6060(98)70145-X · DOI
  91. Benefield, 1996, Regulation of the steps of angiogenesis by human head and neck squamous cell carcinomas, Invasion Metastasis, 16, 291
  92. Patel, 1996, Changes in the immunohistochemical localisation of fibroblast growth factor-2 transforming growth factor-beta 1 and thrombospondin-1 are associated with early angiogenic events in the hyperplastic rat thyroid, J. Endocrinol., 148, 485, 10.1677/joe.0.1480485 · doi:10.1677/joe.0.1480485
  93. Letterio, 1997, TGF--beta a critical modulator of immune cell function, Clin. Immunol. Immunopathol., 84, 244, 10.1006/clin.1997.4409 · DOI
  94. Arteaga, 1993, J. Clin. Invest., 92, 2569, 10.1172/JCI116871 · DOI · Paper page
  95. Fakhrai, 1996, Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy, Proc. Natl. Acad. Sci. USA, 93, 2909, 10.1073/pnas.93.7.2909 · DOI · Paper page
  96. Shull, 1992, Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease, Nature, 359, 693, 10.1038/359693a0 · DOI · Paper page
  97. Borkowski, 1997, A role for TGF-beta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGF-beta1 null mice, J. Clin. Invest., 100, 575, 10.1172/JCI119567 · DOI · Paper page
  98. Borkowski, 1997, Langerhans cells in the TGF- beta 1 null mouse, Adv. Exp. Med. Biol., 417, 307, 10.1007/978-1-4757-9966-8_50 · DOI
  99. Tada, 1991, Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state, J. Immunol., 146, 1077, 10.4049/jimmunol.146.3.1077 · DOI · Paper page
  100. Torre-Amione, 1990, A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance, Proc. Natl. Acad. Sci. USA, 87, 1486, 10.1073/pnas.87.4.1486 · DOI · Paper page
  101. Weiskirch, 1994, Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy, Cancer Immunol. Immunother., 38, 215, 10.1007/BF01533512 · doi:10.1007/bf01533512
  102. Jachimczak, 1996, Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides, Int. J. Cancer, 65, 332, 10.1002/(SICI)1097-0215(19960126)65:3<332::AID-IJC10>3.0.CO;2-C · DOI · Paper page
  103. Park, 1997, Expression of an antisense Transforming Growth Factor-Beta-1 transgene reduces tumorigenicity of EMT6 mammary tumor cells, Cancer Gene Therapy, 4, 42
  104. Tzai, 1998, Antisense oligonucleotide specific for transforming growth factor-beta 1 inhibit both in vitro and in vivo growth of MBT-2 murine bladder cancer, Anticancer Res., 18, 1585
  105. Munger, 1997, Latent transforming growth factor-beta structural features and mechanisms of activation, Kidney Int., 51, 1376, 10.1038/ki.1997.188 · DOI · Paper page
  106. Miyazono, 1988, Latent high molecular weight complex of transforming growth factor-β from human platelets; a high molecular weight complex containing precursor sequences, J. Biol. Chem., 263, 6407, 10.1016/S0021-9258(18)68800-3 · DOI · Paper page
  107. Massagué, 1996, TGF--β signaling Receptors transducers and MAD proteins, Cell, 85, 947, 10.1016/S0092-8674(00)81296-9 · DOI · Paper page
  108. Valverius, 1989, Production of and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells, Cancer Res., 49, 6269
  109. Arteaga, 1988, Transforming growth factor beta potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells, Cancer Res., 48, 3898
  110. Kalkhoven, 1995, The role of TGF--β production in growth inhibition of breast tumor cells by progestins, Int. J. Cancer, 61, 80, 10.1002/ijc.2910610114 · DOI
  111. Barcellos-Hoff, 1994, Transforming growth factor-beta activation in irradiated murine mammary gland, J. Clin. Invest., 93, 892, 10.1172/JCI117045 · DOI · Paper page
  112. Ehrhart, 1997, Latent transforming growth factor beta1 activation in situ quantitative and functional evidence after low-dose gamma-irradiation, Faseb J., 11, 991, 10.1096/fasebj.11.12.9337152 · DOI · Paper page
  113. Fowlis, 1992, Discordant localisation of TGF-β RNA and protein during chemical carcinogenesis in mouse skin, Cell Growth Differ., 3, 81
  114. Esherick, 1993, Transforming growth factorβ1 induction is associated with transforming growth factorβ2 and β3 down-modulation in 12-O-tetradecanoylphorbol-13-acetate-induced skin hyperplasia, Cancer Res., 53, 5507
  115. Jirtle, 1993, Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors, Cancer Res., 53, 3849
  116. Mansbach, 1996, Phenobarbital selectively promotes initiated cells with reduced TGF- beta receptor levels, Carcinogenesis, 17, 171, 10.1093/carcin/17.1.171 · doi:10.1093/carcin/17.1.171
  117. Crawford, 1998, Thrombospondin-1 is a major activator of TGF-β1 in vivo, Cell, 93, 1159, 10.1016/S0092-8674(00)81460-9 · DOI · Paper page
  118. Schultz-Cherry, 1993, Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism [published erratum appears in J. Cell Biol. (1993) Sep; 122 (5) following 1143], J. Cell Biol., 122, 923, 10.1083/jcb.122.4.923 · DOI · Paper page
  119. Schultz-Cherry, 1994, Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system, J. Biol. Chem., 269, 26775, 10.1016/S0021-9258(18)47086-X · DOI · Paper page
  120. Schultz-Cherry, 1994, The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta, J. Biol. Chem., 269, 26783, 10.1016/S0021-9258(18)47087-1 · DOI · Paper page
  121. Penttinen, 1988, Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability, Proc. Natl. Acad. Sci. USA, 85, 1105, 10.1073/pnas.85.4.1105 · DOI · Paper page
  122. Schultz-Cherry, 1995, Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1, J. Biol. Chem., 270, 7304, 10.1074/jbc.270.13.7304 · DOI · Paper page
  123. Guo, 1997, Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1, J. Pept. Res., 50, 210, 10.1111/j.1399-3011.1997.tb01187.x · DOI
  124. Guo, 1997, Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells, Cancer Res., 57, 1735
  125. Raychaudhury, 1994, Comparison of normal and tumorigenic endothelial cells differences in thrombospondin production and responses to transforming growth factor-beta, J. Cell Sci., 107, 39, 10.1242/jcs.107.1.39 · DOI
  126. Sheibani, 1995, Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis, Proc. Natl. Acad. Sci. USA, 92, 6788, 10.1073/pnas.92.15.6788 · DOI · Paper page
  127. Roberts, 1996, Regulation of tumor growth and metastasis by thrombospondin-1, Faseb J., 10, 1183, 10.1096/fasebj.10.10.8751720 · DOI · Paper page
  128. Hsu, 1996, Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1, Cancer Res., 56, 5684
  129. Fynan, 1993, Resistance to inhibition of cell growth by Transforming Growth Factor-β and its role in oncogenesis, Crit. Rev. Oncogenesis, 4, 493
  130. Rodeck, 1994, Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells, Cancer Res., 54, 575
  131. Hurteau, 1994, Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites, Cancer, 74, 93, 10.1002/1097-0142(19940701)74:1<93::AID-CNCR2820740117>3.0.CO;2-P · doi:10.1002/1097-0142(19940701)74:1<93::aid-cncr2820740117>3.0.co;2-p
  132. Havrilesky, 1995, Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta, Cancer Res., 55, 944
  133. Taetle, 1993, Effects of transforming growth factor beta 1 on growth and apoptosis of human acute myelogenous leukemia cells, Cancer Res., 53, 3386
  134. Haddow, 1991, Loss of growth control by TGF--beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation, Oncogene, 6, 1465
  135. Missero, 1991, Escape from transforming growth factor b control and oncogene cooperation in skin tumor development, Proc. Natl. Acad. Sci. USA, 88, 9613, 10.1073/pnas.88.21.9613 · DOI · Paper page
  136. Boukamp, 1995, Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53 rasH oncogene activation and additional chromosome loss, Oncogene, 11, 961
  137. Manning, 1991, Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF--beta) conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta, Oncogene, 6, 1471
  138. Hague, 1993, Escape from negative regulation of growth by transforming growth factor beta and from the induction of apoptosis by the dietary agent sodium butyrate may be important in colorectal carcinogenesis, Cancer Metastasis Rev., 12, 227, 10.1007/BF00665955 · DOI
  139. DeGeest, 1994, Differential response of cervical intraepithelial and cervical carcinoma cell lines to Transforming Growth Factor-β1, Gyn. Oncol., 55, 376, 10.1006/gyno.1994.1310 · doi:10.1006/gyno.1994.1310
  140. Markowitz, 1994, A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene, J. Clin. Invest., 93, 1005, 10.1172/JCI117048 · DOI
  141. Kadin, 1994, Loss of receptors for transforming growth factor β in human T-cell malignancies, Proc. Natl. Acad. Sci. USA, 91, 6002, 10.1073/pnas.91.13.6002 · DOI · Paper page
  142. Capocasale, 1995, Reduced surface expression of transforming growth factor β receptor type II in mitogen-activated T-cells from Sézary patients, Proc. Natl. Acad. Sci. USA, 92, 5501, 10.1073/pnas.92.12.5501 · DOI
  143. Knaus, 1996, A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma, Mol. Cell Biol., 16, 3480, 10.1128/MCB.16.7.3480 · DOI · Paper page
  144. Reiss, 1997, Transforming growth factor-beta and cancer a love-hate relationship?, Oncol Res., 9, 447
  145. Massague, 1996, Serine/threonine kinase receptors mediators of transforming growth factor beta family signals, Cancer Surv., 27, 41
  146. Derynck, 1997, TGF--b receptor signaling, Biochim. Biophys. Acta, 1333, F105
  147. Saitoh, 1996, Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of Transforming Growth Factor-β, J. Biol. Chem., 271, 2769, 10.1074/jbc.271.5.2769 · DOI
  148. Kim, 1996, Genetic change in transforming growth factor beta (TGF--beta) receptor type I gene correlates with insensitivity to TGF--beta 1 in human prostate cancer cells, Cancer Res., 56, 44
  149. Kim, 1998, The conventional transforming growth factor-beta (TGF--beta) receptor type I is not required for TGF--beta 1 signaling in a human prostate cancer cell line LNCaP, Exp. Cell Res., 241, 151, 10.1006/excr.1998.4034 · DOI
  150. Goggins, 1998, Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas, Cancer Res., 58, 5329
  151. Chen, 1998, Transforming Growth Factor-β type I receptor kinase mutant associated with metastatic breast cancer, Cancer Res., 58, 4805
  152. Guo, 1997, Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF--beta1) type I and type II receptors in human prostate cancer, Int. J. Cancer, 71, 573, 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.0.CO;2-D · DOI · Paper page
  153. Baldwin, 1996, Attenuated ALK5 receptor expression in human pancreatic cancer correlation with resistance to growth inhibition, Int. J. Cancer, 67, 283, 10.1002/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B · DOI
  154. Lu, 1997, Presence of two signaling TGF--beta receptors in human pancreatic cancer correlates with advanced tumor stage, Dig. Dis. Sci., 42, 2054, 10.1023/A:1018814416903 · DOI
  155. Baldwin, 1993, Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1, Growth Factors, 8, 23, 10.3109/08977199309029131 · DOI
  156. Kleeff, 1998, Up-regulation of transforming growth factor (TGF-)-beta receptors by TGF--beta1 in COLO-357 cells, J. Biol. Chem., 273, 7495, 10.1074/jbc.273.13.7495 · DOI
  157. Wagner, 1998, Transfection of the type I TGF--beta receptor restores TGF--beta responsiveness in pancreatic cancer, Int. J. Cancer, 78, 255, 10.1002/(SICI)1097-0215(19981005)78:2<255::AID-IJC21>3.0.CO;2-8 · DOI · Paper page
  158. Kimchi, 1988, Absence of TGF--beta receptors and growth inhibitory responses in retinoblastoma cells, Science, 240, 196, 10.1126/science.2895499 · DOI · Paper page
  159. Horie, 1998, Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells, J. Cell Physiol., 175, 305, 10.1002/(SICI)1097-4652(199806)175:3<305::AID-JCP8>3.0.CO;2-S · DOI
  160. Park, 1994, Genetic changes in the transforming growth factor beta (TGF--beta) type II receptor gene in human gastric cancer cells correlation with sensitivity to growth inhibition by TGF--beta, Proc. Natl. Acad. Sci. USA, 91, 8772, 10.1073/pnas.91.19.8772 · DOI · Paper page
  161. Sun, 1994, Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells, J. Biol. Chem., 269, 26449, 10.1016/S0021-9258(18)47215-8 · DOI · Paper page
  162. Kalkhoven, 1995, Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines, Cell Growth Differ., 6, 1151
  163. De Jonge, 1997, Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells, Oncol. Res, 9, 89
  164. Markowitz, 1995, Inactivation of the type II TGF--beta receptor in colon cancer cells with microsatellite instability [see comments], Science, 268, 1336, 10.1126/science.7761852 · DOI · Paper page
  165. Myeroff, 1995, A transforming growth factor β type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability, Cancer Res., 55, 5545
  166. Parsons, 1995, Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer, Cancer Res., 55, 5548
  167. Wang, 1995, Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells, J. Biol. Chem., 270, 22044, 10.1074/jbc.270.37.22044 · DOI · Paper page
  168. Lu, 1995, Mutations of the transforming growth factor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer, Biochem. Biophys. Res. Commun., 216, 452, 10.1006/bbrc.1995.2644 · doi:10.1006/bbrc.1995.2644
  169. Abe, 1996, The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability, Eur. J. Surg. Oncol., 22, 474, 10.1016/S0748-7983(96)92824-3 · DOI
  170. Akiyama, 1996, Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability, Cancer, 78, 2478, 10.1002/(SICI)1097-0142(19961215)78:12<2478::AID-CNCR5>3.0.CO;2-G · doi:10.1002/(sici)1097-0142(19961215)78:12<2478::aid-cncr5>3.0.co;2-g
  171. Ohue, 1996, Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer, Int. J. Cancer, 68, 203, 10.1002/(SICI)1097-0215(19961009)68:2<203::AID-IJC11>3.0.CO;2-B · DOI · Paper page
  172. Lu, 1996, Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers, Cancer Res., 56, 4595
  173. Konishi, 1996, Molecular nature of colon tumors in hereditary nonpolyposis colon cancer familial polyposis and sporadic colon cancer [see comments], Gastroenterology, 111, 307, 10.1053/gast.1996.v111.pm8690195 · DOI · Paper page
  174. Renault, 1996, Microsatellite instability and mutations of p53 and TGF--beta RII genes in gastric cance, r, Human Gen., 98, 601, 10.1007/s004390050267 · DOI
  175. Samowitz, 1997, Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas, Am. J. Pathol., 151, 33
  176. Chang, 1997, Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells, Cancer Res., 57, 2856
  177. Mackay, 1998, 3rd Transfection of the type II TGF--beta receptor into colon cancer cells increases receptor expression inhibits cell growth and reduces the malignant phenotype, Ann. Surg., 227, 781, 10.1097/00000658-199806000-00001 · doi:10.1097/00000658-199806000-00001
  178. Izumoto, 1997, Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas, Cancer Lett., 112, 251, 10.1016/S0304-3835(96)04583-1 · DOI
  179. Takenoshita, 1997, Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers, Oncogene, 14, 1255, 10.1038/sj.onc.1200938 · DOI
  180. Vincent, 1997, Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta, Oncogene, 15, 117, 10.1038/sj.onc.1201166 · doi:10.1038/sj.onc.1201166
  181. Shitara, 1998, Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas, Int. J. Oncol., 12, 1061
  182. Rashid, 1997, Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine, Gastroenterology, 113, 127, 10.1016/S0016-5085(97)70087-8 · DOI
  183. Garrigue-Antar, 1995, Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells, Cancer Res., 55, 3982
  184. Wang, 1997, Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck, Carcinogenesis, 18, 2285, 10.1093/carcin/18.11.2285 · DOI
  185. Orimo, 1998, A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability, Mutat. Res., 382, 115
  186. Lynch, 1998, Mutational analysis of the Transforming Growth Factor β receptor type II gene in human ovarian cancer, Cancer Res., 58, 4227
  187. Grady, 1999, Mutational inactivation of transforming growth factor-b receptor type II in microsatellite stable colon cancers, Cancer Res., 59, 320
  188. De, 1998, Functional characterization of transforming growth factor beta type II receptor mutants in human cancer, Cancer Res., 58, 1986
  189. Knudson, 1985, Heredity cancer oncogenesand antioncogenes, Cancer Res., 45, 1437
  190. Akiyama, 1997, Transforming Growth Factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer, Gastroenterology, 112, 33, 10.1016/S0016-5085(97)70216-6 · DOI
  191. Grady, 1998, Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas, Cancer Res., 58, 3101
  192. Gollerkeri, 1999, Allelic loss of transforming growth factor-β receptor genes in primary breast cancer detected by fluorescence in-situ hybridization lab. invest., Proc. Am. Assoc. Cancer Res., 40, 134
  193. Lin, 1992, Expression cloning of the TGF-β type II receptor a functional transmembrane serine/threonine kinase, Cell, 68, 775, 10.1016/0092-8674(92)90152-3 · DOI · Paper page
  194. Garrigue-Antar, 1996, Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer, Lab. Invest., 75, 263
  195. Munoz-Antonia, 1996, A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression, Cancer Res., 56, 4831
  196. Inagaki, 1993, Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA, Proc. Natl. Acad. Sci. USA, 90, 5359, 10.1073/pnas.90.11.5359 · DOI · Paper page
  197. Guo, 1998, Overexpression of transforming growth factor (TGF-) beta1 type II receptor restores TGF--beta1 sensitivity and signaling in human prostate cancer cells, Cell Growth Differ., 9, 185
  198. Derynck, 1996, Intracellular signalling: The Mad way to do it, Curr. Biol., 6, 1226, 10.1016/S0960-9822(96)00702-6 · DOI · Paper page
  199. Macias-Silva, 1996, MADR2 Is a substrate of the TGF--β receptor and its phosphorylation is required for nuclear accumulation and sigaling, Cell, 87, 1215, 10.1016/S0092-8674(00)81817-6 · DOI · Paper page
  200. Hayashi, 1997, The MAD-related protein Smad7 associates with the TGF-beta receptor and functions as an antagonist of TGF-beta signaling, Cell, 89, 1165, 10.1016/S0092-8674(00)80303-7 · DOI · Paper page

200 of 272 shown

Cited by

See all 118

Metadata

Authors
Reiss, M.
Venue
Microbes and Infection
Publisher
Elsevier BV
Published
1999-12
Volume
1
Issue
15
Pages
1327-1347
ISSN
1286-4579 (ISSN-L)
OpenAlex
W2086286077
Cited by
118
References
6
FWCI
2.83
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TGF-β and cancer. https://app.cochat.ai/papers/10.1016/s1286-4579(99)00251-8
The paper
Reiss, M. (1999). TGF-β and cancer. Microbes and Infection. https://doi.org/10.1016/s1286-4579(99)00251-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.